<DOC>
	<DOC>NCT00921284</DOC>
	<brief_summary>The main objective if to evaluate the sparing effect of dexmedetomidine on the doses of propofol and remifentanil.</brief_summary>
	<brief_title>Influence of Dexmedetomidine on a Closed-Loop Anesthesia System</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>male patients scheduled for a general anesthesia age lower than 18 years allergy to propofol, or to soja or to peanuts, or to sufentanil, to remifentanil, or to morphine,or to a myorelaxant or to an excipient, hypersensibility to sufentanil, or to remifentanil, or to other derivate of fentanyl, history of central nervous system disease, patients receiving a psychotropic treatment or an agonistantagonist opiate, hypovolemic patients, patients receiving a cardiovascular treatment, expected bleeding surgical procedure, simultaneous general and locoregional anesthesia, severe hepatic insufficiency.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>